Aerogenic vaccination of mice with Mycobacterium bovis BCG
- PMID: 3775862
- DOI: 10.1016/0041-3879(86)90007-3
Aerogenic vaccination of mice with Mycobacterium bovis BCG
Abstract
The course of infection with Mycobacterium bovis BCG Pasteur was followed against time in groups of mice vaccinated by either the aerogenic or subcutaneous route. The generation of acquired protective immunity and immunological memory was determined in each group by adoptive immunisation procedures. In addition, subcutaneously vaccinated mice were tested for their ability to resist an aerogenic challenge with a lethal dose of M. tuberculosis. No overall qualitative differences in the magnitude or longevity of antituberculosis immunity in mice vaccinated by the two procedures were observed. It is concluded that aerogenic vaccination offers no immunological advantage over vaccination by the subcutaneous route.
Similar articles
-
Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis.Vaccine. 2006 Mar 15;24(12):2071-8. doi: 10.1016/j.vaccine.2005.11.017. Epub 2005 Nov 21. Vaccine. 2006. PMID: 16332403
-
Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations.Tuberculosis (Edinb). 2016 Dec;101:174-190. doi: 10.1016/j.tube.2016.09.004. Epub 2016 Oct 8. Tuberculosis (Edinb). 2016. PMID: 27865390 Free PMC article.
-
Immunization of mice with Mycobacterium leprae/Mycobacterium bovis BCG admixtures: modulation of the acquired response to BCG.Int J Lepr Other Mycobact Dis. 1987 Jun;55(2):293-8. Int J Lepr Other Mycobact Dis. 1987. PMID: 3298475
-
A strategy to improve the efficacy of vaccination against tuberculosis and leprosy.Immunol Today. 1992 Sep;13(9):342-5. doi: 10.1016/0167-5699(92)90168-7. Immunol Today. 1992. PMID: 1466750 Review.
-
[Novel vaccines against M. tuberculosis].Kekkaku. 2006 Dec;81(12):745-51. Kekkaku. 2006. PMID: 17240920 Review. Japanese.
Cited by
-
Trying to See the Forest through the Trees: Deciphering the Nature of Memory Immunity to Mycobacterium tuberculosis.Front Immunol. 2018 Mar 8;9:461. doi: 10.3389/fimmu.2018.00461. eCollection 2018. Front Immunol. 2018. PMID: 29568298 Free PMC article. Review.
-
Anamnestic responses of mice following Mycobacterium tuberculosis infection.Infect Immun. 2005 Sep;73(9):6110-8. doi: 10.1128/IAI.73.9.6110-6118.2005. Infect Immun. 2005. PMID: 16113332 Free PMC article.
-
Naturally attenuated, orally administered Mycobacterium microti as a tuberculosis vaccine is better than subcutaneous Mycobacterium bovis BCG.Infect Immun. 2002 Mar;70(3):1566-70. doi: 10.1128/IAI.70.3.1566-1570.2002. Infect Immun. 2002. PMID: 11854245 Free PMC article.
-
Systemic BCG immunization induces persistent lung mucosal multifunctional CD4 T(EM) cells which expand following virulent mycobacterial challenge.PLoS One. 2011;6(6):e21566. doi: 10.1371/journal.pone.0021566. Epub 2011 Jun 24. PLoS One. 2011. PMID: 21720558 Free PMC article.
-
Protective immunity to experimental tuberculosis by mannophosphoinositides of mycobacteria.Med Microbiol Immunol. 1988;177(5):265-84. doi: 10.1007/BF00189412. Med Microbiol Immunol. 1988. PMID: 2845237
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical